Side-by-side comparison of AI visibility scores, market position, and capabilities
Egypt's leading digital brokerage with 11% EGX retail market share, $4.2B 2024 trading volume, and 47% gold mutual fund AUM; $37.76M from Prosus and YC serving 82% of new EGX registrants.
Thndr is Cairo-based Egypt's leading digital investment brokerage platform — enabling first-time investors across Egypt and the MENA region to access the Egyptian Stock Exchange (EGX), gold mutual funds, and other investment products through a mobile-first app that removes the minimum balance requirements and complexity of traditional brokerage. Backed by Y Combinator with $37.76 million raised including a $15.7 million Series A led by Prosus in May 2025, Thndr processed $4.2 billion in trading volume in 2024, captured 11% of retail traded value on the EGX, and holds 47% of Egypt's gold mutual fund AUM (assets under management).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.